University College Dublin — Sponsor Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

3 Recruiting

6 Completed trials

9 Countries active

18 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 6 Phase IV: 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

6 of 6 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Endometrial adenocarcinoma 1

Top IMPs

SEMAGLUTIDE 2 COLCHICINE 1 DIPHENHYDRAMINE HYDROCHLORIDE 1 DOXORUBICIN HYDROCHLORIDE 1 DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL 1 DURVALUMAB 1 EMPAGLIFLOZIN 1 EPOETIN ALFA 1 IOHEXOL 1 IOPAMIDOL 1 IRON 1 LEVONORGESTREL 1

All trials

11 total

POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychologic… Pending

2024-515147-32-02 Phase II 1 country DIPHENHYDRAMINE HYDROCHLORIDE; DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EX…
A clinical trial studying the effect of Tirzepatide in women living with endometrial cancer Pending

2025-523877-40-00 Phase II 1 country LEVONORGESTREL; TIRZEPATIDE
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight … Recruiting

2024-513168-24-00 Phase II 3 countries SEMAGLUTIDE
EPO-TRAUMA Recruiting

2023-506081-31-00 Phase III 6 countries EPOETIN ALFA
Randomised Placebo-Controlled Trial of Early Targeted Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight I… Recruiting

2024-516846-20-00 Phase III 2 countries PARACETAMOL; SODIUM CHLORIDE
Semaglutide for people with obesity and resistant hypertension (SUPPORT): a pilot, randomized, parallel-group, integrated, multicentre clini… Ended

2024-513958-29-00 Phase III 1 country SEMAGLUTIDE
Vaccination to prevent Mpox Infection (MPOX-VAX Study) Ended

2023-507881-19-00 Phase IV 1 country MODIFIED VACCINIA ANKARA – BAVARIAN NORDIC LIVE VIRUS
The impact of Empagliflozin on Left atrIal Volume and the feasibility of using Fitbit and mHealth to prescribe Exercise in non-diabetic Pre-… Ended

2024-512062-34-00 Phase II 1 country EMPAGLIFLOZIN
Daily versus alternate day oral iron supplementation for the treatment of iron deficiency anaemia in pregnancy (IronMother) Ended

2024-512064-61-00 Phase IV 1 country IRON
CONCISE COlchicine iN Circulating Inflammatory markers after StrokE Ended

2023-506967-33-00 Phase II 1 country COLCHICINE
A Phase 2 Study of Tremelimumab (Day 1 only), Durvalumab (MEDI4736) and Trans-arterial catheter chemoembolization (TACE)in patients with adv… Ended

2023-510117-26-00 Phase II 1 country DOXORUBICIN HYDROCHLORIDE; DURVALUMAB; IOHEXOL; IOPAMIDOL; TREMELIMUMAB

Showing 1–11 of 11 trials

← All sponsors A–Z